Učitavanje...
Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...
Spremljeno u:
Glavni autori: | , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BMC
2017-11-01
|
Serija: | BMC Pulmonary Medicine |
Teme: | |
Online pristup: | http://link.springer.com/article/10.1186/s12890-017-0503-6 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|